Zdrowie i gospodarka · 26/10/2004

FDA Clears SERZONE (Nefazodone Hydrochloride) for Sale

The US Food and Drug Administration (FDA) has ruled that the antidepressant medication SERZONE (nefazodone hydrochloride) will not be removed from the market due to safety or efficacy concerns, allowing the FDA to continue reviewing Abbreviated New Drug Applications (ANDAs) for the medication.